Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
UBS
Baxter
Citi
Express Scripts
Mallinckrodt
Deloitte
Chubb

Generated: June 22, 2018

DrugPatentWatch Database Preview

ORPHENGESIC Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Orphengesic patents expire, and when can generic versions of Orphengesic launch?

Orphengesic is a drug marketed by Galt Pharms and is included in one NDA.

The generic ingredient in ORPHENGESIC is aspirin; caffeine; orphenadrine citrate. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
Summary for ORPHENGESIC
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:ORPHENGESIC at DailyMed
Drug patent expirations by year for ORPHENGESIC

US Patents and Regulatory Information for ORPHENGESIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galt Pharms ORPHENGESIC aspirin; caffeine; orphenadrine citrate TABLET;ORAL 075141-001 May 29, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Galt Pharms ORPHENGESIC FORTE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 075141-002 May 29, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Accenture
Deloitte
Boehringer Ingelheim
Covington
Harvard Business School
Merck
UBS
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.